Bioceltix S.A. (WSE:BCX)
Poland
· Delayed Price · Currency is PLN 88.60
+1.80 (2.07%)
Apr 28, 2026, 5:00 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 436.31 million as of April 28, 2026. Its market cap has decreased by -7.52% in one year.
Market Cap
436.31M
Enterprise Value
412.76M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
88.60
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 436.31M, an increase of 279.27%. That is a compound annual growth rate of 34.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 427.44M | 11.86% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIOTON | 359.34M |
| Captor Therapeutics Spolka Akcyjna | 508.27M |
| Ryvu Therapeutics | 553.73M |
| Synthaverse | 236.37M |
| Mabion | 133.82M |
| Molecure | 118.06M |
| NanoGroup | 108.06M |
| Poltreg | 80.21M |